Workshop: The Meaning(s) and Value(s) of Early Detection of Disease
Wellcome Genome Campus
Wellcome Trust Genome Campus, Hinxton, Saffron Walden CB10 1SA, UK
Research and policy across multiple areas of healthcare (and beyond) emphasise the importance of early detection of disease. However, the meaning and value of early detection are not always transparent. This workshop will provide a forum for an interdisciplinary exploration of emerging approaches aimed at detecting early disease by means of diverse genetic, molecular and digital markers, asking:
- What makes detection valuable in different contexts and to different actors?
- What is the relationship between detecting, diagnosis and screening for disease?
- What is the place of ‘actionability’, and how is actionability established?
- How can we explore these questions from philosophical, sociological and public health perspectives?
- Dr Stuart Hogarth, Department of Sociology, University of Cambridge
- Prof Carol Brayne, Department of Public Health, University of Cambridge
- Dr Stephen John, Department of Public Health, University of Cambridge
- Dr Christine Patch, Genomics England & Wellcome Connecting Science
- Dr Ignacia Arteaga, Department of Social Anthropology, University of Cambridge
- Dr Richard Milne and Dr Alessia Costa, Society and Ethics Research, Wellcome Connecting Science
The workshop is part of the Wellcome Trust-funded study SPACE, on the ethical and social aspects of using digital technologies to detect cognitive changes associated with Alzheimer’s disease. It is co-hosted by Wellcome Connecting Science and Cambridge Public Health.
Artwork: Detecting cancer in human tissues, LM. Credit: Aamir Ahmed, Jane Pendjiky and Michael Millar.
Workshop: early disease detection